Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 37.50B |
| Enterprise value | 38.01B |
| Trailing P/E | 14.12 |
| Forward P/E | 15.38 |
| PEG ratio (5-yr expected) | 5.14 |
| Price/sales (ttm) | 3.77 |
| Price/book (mrq) | 2.59 |
| Enterprise value/revenue | 3.81 |
| Enterprise value/EBITDA | 9.96 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.13 |
| 52-week change 3 | 32.28% |
| S&P500 52-week change 3 | 18.47% |
| 52-week high 3 | 319.76 |
| 52-week low 3 | 194.63 |
| 50-day moving average 3 | 266.74 |
| 200-day moving average 3 | 281.70 |
Share statistics
| Avg vol (3-month) 3 | 1.01M |
| Avg vol (10-day) 3 | 780.86k |
| Shares outstanding 5 | 144.82M |
| Implied shares outstanding 6 | 144.82M |
| Float 8 | 144.38M |
| % held by insiders 1 | 0.68% |
| % held by institutions 1 | 90.87% |
| Shares short (30 Aug 2023) 4 | 3.14M |
| Short ratio (30 Aug 2023) 4 | 3.81 |
| Short % of float (30 Aug 2023) 4 | 2.44% |
| Short % of shares outstanding (30 Aug 2023) 4 | 2.17% |
| Shares short (prior month 30 Jul 2023) 4 | 3.42M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 3:1 |
| Last split date 3 | 17 Jan 2001 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 29 Jun 2023 |
Profitability
| Profit margin | 26.72% |
| Operating margin (ttm) | 26.24% |
Management effectiveness
| Return on assets (ttm) | 6.51% |
| Return on equity (ttm) | 20.25% |
Income statement
| Revenue (ttm) | 9.97B |
| Revenue per share (ttm) | 69.08 |
| Quarterly revenue growth (yoy) | -5.10% |
| Gross profit (ttm) | 7.9B |
| EBITDA | 3.09B |
| Net income avi to common (ttm) | 2.66B |
| Diluted EPS (ttm) | 18.23 |
| Quarterly earnings growth (yoy) | -44.10% |
Balance sheet
| Total cash (mrq) | 6.08B |
| Total cash per share (mrq) | 41.97 |
| Total debt (mrq) | 6.59B |
| Total debt/equity (mrq) | 45.57% |
| Current ratio (mrq) | 3.27 |
| Book value per share (mrq) | 99.91 |
Cash flow statement
| Operating cash flow (ttm) | 1.43B |
| Levered free cash flow (ttm) | 1.71B |
© 2023 Yahoo. All rights reserved.
